Omada Health, Inc. stock analysis
Want to see OMDA full AI Analyst Report?
Omada Health, Inc. (OMDA) Stock Price & Analysis
OMDA Stock Chart & Stats
- Day’s Range
- $13.15 - $14.41
- 52-Week Range
- $10.28 - $25.45
- Previous Close
- $14.08
- Volume
- N/A
- Average Volume (3M)
- 1.29M
- Market Cap
- $817.04M
- Enterprise Value
- $1.15B
- Total Cash (Recent Filing)
- $243.15M
- Total Debt (Recent Filing)
- $0
- Price to Earnings (P/E)
- 55.4
- Beta
- 2.29
- Next Earnings
- Mar 11, 2027 (Est.)
- EPS Estimate
- 0.12
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Member Growth And Retention
Rapid member growth alongside better retention and longer tenure indicates stronger engagement and improving customer value. These trends can support recurring revenue, deepen program outcomes, and increase the durability of payer and employer relationships over the next several quarters.
Margin And Cash-Flow Improvement
Higher gross margins and the move toward positive cash generation show improving delivery efficiency and operating leverage. If sustained, these gains can reduce funding needs, support continued investment in care and technology, and strengthen the company’s ability to scale profitably.
Expanding Distribution And Covered Lives
Embedding programs at the benefit level and expanding through major distribution channels can lower enrollment friction and broaden access to eligible members. The resulting reach creates a stronger platform for recurring growth across prevention, hypertension, diabetes, and related services.
Bears Say
Profitability Not Yet Fully Established
The business has not yet demonstrated sustained GAAP profitability, so its improving financial trajectory remains dependent on continued growth and operating execution. Persistent losses could limit retained capital and make future earnings more sensitive to investment or cost increases.
GLP-1 Coverage Uncertainty
Potential reductions or delays in employer GLP-1 coverage could affect demand, enrollment timing, and revenue from an important care opportunity. Uncertainty around benefit decisions also makes planning and forecasting less predictable as customers evaluate healthcare spending.
Rising Buyer And Cost Pressure
Higher healthcare costs and tougher ROI requirements can increase sales friction and place pressure on contract economics. More prevalent performance guarantees may also transfer additional execution risk to Omada and make durable margin expansion harder to achieve.
Omada Health, Inc. News
Omada Health’s Growth at Risk as Volatile Enrollment and Non-Exclusive Partnerships Threaten Revenue Stability
Omada Health, Inc. (OMDA) has disclosed a new risk, in the Sales & Marketing category. Omada Health, Inc. faces revenue volatility because its fees depend on monthly enrollment levels from
Omada Health’s Strong Q3 Execution and Raised Outlook Support Buy Rating; $35 Price Target Unchanged
BTIG analyst David Larsen has reiterated their bullish stance on OMDA stock, giving a Buy rating today. David Larsen’s rating is based on Omada Health’s strong third-quarter execution and improved
Craig Hettenbach Reiterates Buy on Omada Health, Maintains $30 Price Target on Expanding Digital Health and GLP-1 Tailwinds
Morgan Stanley analyst Craig Hettenbach maintained a Buy rating on Omada Health, Inc. today and set a price target of $30.00. Craig Hettenbach has given his Buy rating due to
Buy Rating Reiterated on Omada Health as Growth, Margin Outlook and Valuation Remain Compelling; Price Target Unchanged at $35
In a report released today, David Larsen from BTIG reiterated a Buy rating on Omada Health, Inc., with a price target of $35.00. David Larsen has given his Buy rating
OMDA FAQ
What was Omada Health, Inc.’s price range in the past 12 months?
What is Omada Health, Inc.’s market cap?
When is Omada Health, Inc.’s upcoming earnings report date?
How were Omada Health, Inc.’s earnings last quarter?
Is Omada Health, Inc. overvalued?
Does Omada Health, Inc. pay dividends?
What is Omada Health, Inc.’s EPS estimate?
How many shares outstanding does Omada Health, Inc. have?
What happened to Omada Health, Inc.’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Omada Health, Inc.?
What is the TipRanks Smart Score and how is it calculated?
Omada Health, Inc. Stock Smart Score
Company Description
Omada Health, Inc.
Omada Health, Inc., together with its subsidiary, Physera, Inc., provides a range of virtual care programs in the United States. The company offers cardiometabolic programs for prediabetes, diabetes, and hypertension; a physical therapy program to address musculoskeletal conditions; other support programs for members taking glucagon-like peptide-1 agonists in its cardiometabolic program; and weight management programs, as well as various behavioral health support programs. It also delivers virtual care. The company offers its programs for employers, health plans and systems, and pharmacy benefits managers through its direct sales force and channel partners. The company was incorporated in 2011 and is headquartered in South San Francisco, California.
- Sector
- General
- Industry
- Medical - Healthcare Information Services
- CEO
- Sean Duffy
- Employees
- 946
- Website
- www.omadahealth.com
- Address
- 611 Gateway Blvd, San Francisco, CA, 94080, US
Omada Health, Inc. (OMDA) Earnings & Revenues
OMDA Company Deck
OMDA Earnings Call
Earnings Call SentimentPositive
The call was strongly positive. Omada reported record revenue, gross margin, net income, adjusted EBITDA, member tenure, and cash generation, while raising full-year revenue and adjusted EBITDA guidance. Growth was supported by diabetes and hypertension programs, improved enrollment conversion, broader distribution, longer member engagement, and lower cost to serve. The main challenges were normal Q4 seasonal moderation, uncertainty around employer GLP-1 coverage and the timing of the extended selling season, rising healthcare costs, and expected near-term investment-related moderation in adjusted EBITDA.
View all OMDA earnings summariesOMDA Stock 12 Month Forecast
Average Price Target
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 6 | 2 | 14 |
| Technical Analysis | 6 | 2 | 2 |
| Moving Averages | 0 | 0 | 12 |






